1 not yet recruiting, 1 recruiting, 1 terminated. 3 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 3 | Not yet recruiting 1, Recruiting 1, Terminated 1 |
Follow blinatumomab: new trials by email Literature Review of blinatumomab trials Research Report on blinatumomab
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety of Low-Dose Blinatumomab in the Treatment of Refractory Autoimmune Encephalitis and Autoimmune Cerebellitis Blinatumomab - Autoimmune Encephalitis (AE), Autoimmune Cerebellitis | Phase 4 | Not yet recruiting | Beijing Tiantan Hospital | 12 | 2026-06-24 | 2026-07-06 |
| Blinatumomab for Relapsed Acute B Lymphoblastic Leukemia After Transplantation Blinatumomab - Acute B-cell Lymphoblastic Leukemia | Phase 4 | Recruiting | Suping ZHANG | 60 | 2023-09-01 | 2024-04-01 |
| Feasibility Study to Evaluate Outpatient Blinatumomab in Subjects With Minimal Residual Disease (MRD) of B-precursor Acute Lymphoblastic Leukemia (ALL) Blinatumomab, Current Wearable Heatlth Monitoring System (CWHMS) - B-precursor Acute Lymphoblastic Leukemia | Phase 4 | Terminated | Amgen | 10 | 2021-08-26 | 2025-05-18 |
Autoimmune Diseases of the Nervous System (1) · Leukemia (1) · Neoplasm, Residual (1) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (1) · Recurrence (1)
Amgen (1) · Beijing Tiantan Hospital (1) · Suping ZHANG (1)
China (2) · United States (1)
Wangshu Xu (1)